Labiotech.eu

News and Trends 25 Aug 2022

Ilya Pharma finalizes global patent coverage for modified lactic acid bacteria to treat wounds

Ilya Pharma, a Swedish clinical stage biopharma company focused on delivering local immunotherapies to patients, has announced the issue of four new patents. These are: one in India, and continuation patents in China, Australia and the U.S. This means the company’s method for using modified bacteria for treatment of both mucosal and cutaneous wounds in […]

August 25, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 25 Aug 2022

Evotec SE acquires highly-flexible drug manufacturing space for €1

A clinical and commercial manufacturing platform for small molecule therapeutics has expanded following an acquisition signed for. Evotec SE made the announcement today (August 25) after signing the contract yesterday for €1 to take Central Glass Germany GmbH from Japanese manufacturing company Central Glass Co. Ltd. It will now operate as Evotec Drug Substance (Germany) […]

August 25, 2022 - 2 minutesmins - By Liza Laws

huntingtons disease dementia prilenia therapeutics

News and Trends 24 Aug 2022

Clearance given to clinical trial with potential to change course of brain disease

A trial to look at gene therapy, BV-01, for Huntington’s Disease has been given the go ahead to take place in France and has ‘the potential to change the course of the devastating disease. Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, received clearance for the phase 1/2 […]

August 24, 2022 - 3 minutesmins - By Liza Laws

acute respiratory distress syndrome pantherna therpeutics inflammatory lung disease

News and Trends 24 Aug 2022

Vocal biomarker agreement set to benefit patients with COPD in India

A new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease (COPD) in India is being developed after a multi-year agreement was signed. The agreement between Sonde Health, a vocal biomarker company, and Koye Pharmaceuticals, a pharma organization, was signed today (August 24). The deal represents Sonde’s first partnership with a pharmaceutical company. Develop […]

August 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 24 Aug 2022

Hera Biotech bags $1.9M for endometriosis diagnostic test

San Antonio-based medical device start-up Hera Biotech has closed an oversubscribed $1.9 million seed financing round to support its commercialization strategy for its non-surgical diagnostic test for endometriosis, MetriDx. The funds will be used to complete an in-patient human clinical study, expand Hera’s IP portfolio, and support a regulatory pathway with the U.S. FDA. Investors […]

August 24, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 24 Aug 2022

Gene therapies for lung cancer identified by international team of scientists

Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international team of scientists have discovered. CRISPR genome-editing is a powerful tool that gives scientists a cheap and easy way to find and alter a specific piece of DNA within a cell – the ‘cut and paste’ of the biological world. […]

August 24, 2022 - 2 minutesmins - By Liza Laws

News and Trends 24 Aug 2022

Study findings could lead to new anti-cancer drugs

German scientists say a drug already approved for other purposes can negate how tumor cells protect themselves from the immune system. Many tumor cells mist themselves with a protective ‘perfume’ that disables the immune system. But a drug already approved for other purposes can apparently render this weapon harmless. This is the conclusion of a […]

August 24, 2022 - 4 minutesmins - By Jim Cornall

Optics11 Life receives €5 million in funding for drug development

News and Trends 24 Aug 2022

Millions in funding and new board members for Belgian mRNA company

The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing. Belgium-based eTheRNA will use the money to expand investment in its integrated mRNA technology platform and further pursue its new initiatives for a partnership-driven business strategy. The round was led by Novalis LifeSciences LLC with participation from Professor Kenneth Chien, […]

August 24, 2022 - 3 minutesmins - By Liza Laws

covid-19 vaccine emergency use authorization

More News! 24 Aug 2022

COVID-19 vaccine less sensitive to mutations being developed in Sweden

A new generation of coronavirus vaccine is being developed by Swedish researchers from the Karolinska Institutet. The vaccine is being specifically designed to be less sensitive to mutations and better equipped for any future strains. Promising results The vaccine showed promising results in mice in a newly published study in EMBO Molecular Medicine, and the researchers […]

August 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 24 Aug 2022

Potential new treatment for angioimmunoblastic T-cell lymphoma?

A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from which the T cells in the blood develop. However, the underlying mechanism by which AITL develops was unknown. Now, a team from the University of Tsukuba in Japan have shown that B […]

August 24, 2022 - 3 minutesmins - By Jim Cornall

In Depth 24 Aug 2022

To reach Mars, we need biotechnology

As we prepare for long-distance space travel and life on Mars, biotechnology will be essential to make spaceships no longer dependent on Earth’s constant supply. “As human beings, we need a constant supply of oxygen. We need constant access to nutritious food, clean water and a safe and clean waste disposal system,” says Italian astronaut […]

August 24, 2022 - 11 minutesmins - By Clara Rodríguez Fernández

News and Trends 24 Aug 2022

BioAge partners with Age Labs to study healthy life length

BioAge Labs, Inc., a biotech company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, has partnered with Age Labs AS, a diagnostic company that develops tests for the early detection of age-related diseases. Under the terms of the agreement, BioAge will perform multi-omics analyses on samples and health records […]

August 24, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Ilya Pharma finalizes global patent coverage for modified lactic acid bacteria to treat wounds

Evotec SE acquires highly-flexible drug manufacturing space for €1

Clearance given to clinical trial with potential to change course of brain disease

Vocal biomarker agreement set to benefit patients with COPD in India

Hera Biotech bags $1.9M for endometriosis diagnostic test

Gene therapies for lung cancer identified by international team of scientists

Study findings could lead to new anti-cancer drugs

Millions in funding and new board members for Belgian mRNA company

COVID-19 vaccine less sensitive to mutations being developed in Sweden

Potential new treatment for angioimmunoblastic T-cell lymphoma?

To reach Mars, we need biotechnology

BioAge partners with Age Labs to study healthy life length

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!